A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Public

Shared by NobleBlocks on Aug 26, 2015 • 12:00 AM UTC

Authors:

Laura R. Saunders

Alexander J. Bankovich

Wade C. Anderson

Abstract

Targeting DLL3 with an antibody-drug conjugate eliminates tumor-initiating cells in high-grade pulmonary neuroendocrine cancers.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

(0)

No comments yet

Be the first to share your thoughts!